Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY-NC 4.0International Journal of Women's Health

Single-Cell Immune Cis-eQTL Mendelian Randomization Prioritizes Cell-Type-Resolved Candidate Causal Genes for Endometriosis

  1. 1Department of Urology, The Second People’s Hospital of Wuhu, Wuhu, Anhui, People’s Republic of China

Abstract

Background: Endometriosis has a substantial immune component, but the cellular contexts of genetically regulated disease susceptibility remain incompletely resolved.

Methods: We tested single-cell cis-eQTL instruments from 20 OneK1K peripheral-blood cell types against FinnGen R12 endometriosis (20,190 cases; 130,160 controls) using single-variant Mendelian randomization (MR), colocalization and sensitivity analyses. Benjamini–Yekutieli (BY) correction distinguished conservative findings from an exploratory Benjamini–Hochberg (BH) screen. Directional consistency, bulk-blood MR and lesion expression provided contextual comparisons.

Results: Across 9157 unique gene–cell-type tests, 135 associations in 61 genes reached BH-FDR < 0.05. Colocalization at the default prior prioritized 10 genes (6 protein-coding) across 28 pairs. LOC102723878 and RUVBL1 were also BY-robust; IGF1R in natural killer (NK) cells was BH-supported but not BY-robust (PP4 = 0.89; OR 1.11 per SD higher expression). Its NK attribution reflects instrument availability and does not establish exclusivity. Colocalization was prior-sensitive. Directional concordance in a partly overlapping sample (8/8) was descriptive. Bulk-blood MR nominated 3/6 testable protein-coding genes. IGF1R lesion expression showed a nonsignificant upward trend (P = 0.101).

Conclusion: The analysis prioritizes immune-context candidate genes for functional study. IGF1R remains an exploratory, mechanistically unresolved nomination. Genetic support and protein tractability do not establish therapeutic benefit or reproductive safety; experimental validation is required.

Related

  1. Identification of genetically supported candidate therapeutic targets for angina pectoris using mendelian randomization
    Zixuan Wang, Dexin Wang, Longke Ran +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Immune Cell-Mediated Interactions Between the Gut Microbiome and Endometriosis: A Mendelian Randomization Investigation
    Xiaohui Huang, Rui Zhong, Lele Pan
    International Journal of Women's HealthPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsPMCEurope PMC
  3. Plasma Angiotensin‐Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome‐Wide Mendelian Randomization and a Large Prospective Cohort Study
    Peiyuan Huang, Haibo Tang, Zeying Feng +4
    Journal of the American Heart AssociationPeer-reviewedCC BYFull textPhysiologyCrossref
  4. HEXB as a Candidate Target Gene in Keloid Radiotherapy: Based on Multi-Omics Analysis and Mendelian Randomization.
    Yuxuan Shang, Shuangshuang Gao, Xiaofang Guan
    Clinical, cosmetic and investigational dermatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Cell-type-resolved colocalisation prioritises KCNIP2 as a candidate epilepsy drug-target detectable at inhibitory-neuron but not bulk-tissue resolution: a Mendelian randomisation and colocalisation study.
    Aytac Gul
    Frontiers in geneticsPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCPMC
BibTeX
@article{wang2026singlecell,
  title = {{Single-Cell Immune Cis-eQTL Mendelian Randomization Prioritizes Cell-Type-Resolved Candidate Causal Genes for Endometriosis}},
  author = {Xin Wang and Guanglei Yao and Wei Ding},
  journal = {International Journal of Women's Health},
  year = {2026},
  month = oct,
  doi = {10.2147/ijwh.s643362},
  url = {https://doi.org/10.2147/ijwh.s643362},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Single-Cell Immune Cis-eQTL Mendelian Randomization Prioritizes Cell-Type-Resolved Candidate Causal Genes for Endometriosis
AU  - Xin Wang
AU  - Guanglei Yao
AU  - Wei Ding
PY  - 2026
DA  - 2026/10/30
JO  - International Journal of Women's Health
DO  - 10.2147/ijwh.s643362
UR  - https://doi.org/10.2147/ijwh.s643362
AB  - Background: Endometriosis has a substantial immune component, but the cellular contexts of genetically regulated disease susceptibility remain incompletely resolved.  Methods: We tested single-cell cis-eQTL instruments from 20 OneK1K peripheral-blood cell types against FinnGen R12 endometriosis (20,190 cases; 130,160 controls) using single-variant Mendelian randomization (MR), colocalization and sensitivity analyses. Benjamini–Yekutieli (BY) correction distinguished conservative findings from an exploratory Benjamini–Hochberg (BH) screen. Directional consistency, bulk-blood MR and lesion expression provided contextual comparisons.  Results: Across 9157 unique gene–cell-type tests, 135 associations in 61 genes reached BH-FDR < 0.05. Colocalization at the default prior prioritized 10 genes (6 protein-coding) across 28 pairs. LOC102723878 and RUVBL1 were also BY-robust; IGF1R in natural killer (NK) cells was BH-supported but not BY-robust (PP4 = 0.89; OR 1.11 per SD higher expression). Its NK attribution reflects instrument availability and does not establish exclusivity. Colocalization was prior-sensitive. Directional concordance in a partly overlapping sample (8/8) was descriptive. Bulk-blood MR nominated 3/6 testable protein-coding genes. IGF1R lesion expression showed a nonsignificant upward trend (P = 0.101).  Conclusion: The analysis prioritizes immune-context candidate genes for functional study. IGF1R remains an exploratory, mechanistically unresolved nomination. Genetic support and protein tractability do not establish therapeutic benefit or reproductive safety; experimental validation is required.
SN  - 1179-1411
ER  -